(801.6) Developing a Prenatal Acute Exposure and Medical Countermeasure Evaluation Model for Organophosphate Compounds in a Genetically Modified Mouse

Poster Board Number: A208

Eric Herrera (U.S. Army Medical Research Institute of Chemical Defense, U.S. Army Medical Research Institute of Chemical Defense), Timothy Barry (U.S. Army Medical Research Institute of Chemical Defense, U.S. Army Medical Research Institute of Chemical Defense), Aishwarya Sriraman (U.S. Army Medical Research Institute of Chemical Defense, U.S. Army Medical Research Institute of Chemical Defense), Karen Brecht (U.S. Army Medical Research Institute of Chemical Defense), Sandra DeBus (U.S. Army Medical Research Institute of Chemical Defense), Ki Ma (U.S. Army Medical Research Institute of Chemical Defense), Hilary Mccarren (U.S. Army Medical Research Institute of Chemical Defense), C. Cadieux (U.S. Army Medical Research Institute of Chemical Defense)

Organophosphate (OPs) compounds make up the most common class of pesticides as well as chemical warfare nerve agents (CWNA), all of which covalently inhibit the active site of acetylcholinesterase (AChE), resulting in intoxication via a cholinergic crisis. While the biochemical mechanism of action resulting in acute intoxication of an exposed individual is well understood, less is known about the mechanism of OP intoxication via other exposure routes, particularly prenatal exposure. The clinical effects of non-acute prenatal OP exposure have been previously studied primarily in cases involving diet and agricultural labor, while case studies documenting the effects on conception of acute exposure during chemical warfare attacks (Japan 1995, Syria 2013 and 2017) have also been published. Such exposure events were linked to a range of serious neurodevelopmental anomalies in children, but the underlying mechanism of action as well as the potential benefits of medical countermeasures have not been clearly elucidated. A robust human-relevant animal model to test both is therefore essential for evaluating current and future OP countermeasures. The present study used a novel humanized mouse strain expressing human AChE and an inactivated native serum carboxylesterase to create a prenatal acute exposure and emergency medical countermeasure evaluation model. Pregnant mice were acutely exposed to an OP at a critical point in cholinergic development, generally equivalent to the first trimester in humans. Dams were challenged with either sarin or the pesticide paraoxon, followed by either a saline vehicle control or 2-PAM and an atropine/midazolam cocktail, the currently fielded emergency treatment for OP intoxication. Mice were allowed to carry pups to term, and upon reaching maturity, cortex, cerebellum, bone marrow and gonads were collected from offspring in each exposure group. Phenotypical and histopathological evaluation of tissues and other factors in dams and offspring were evaluated. Gene expression analyses conducted for each tissue generated a detailed profile associated with each OP exposure/treatment group, providing robust criteria for model development. The resulting data demonstrated a significant beneficial impact of medical countermeasures for both sarin and paraoxon exposures, significantly reducing the amount and the scope of gene expression changes induced by OP exposure. This model provides insight into the developmental pathologies resulting from prenatal acute OP exposure as well as serves as an evaluation model for future treatments.

Support or Funding Information

The views expressed are those of the author(s) and do not reflect the official policy of the DoA, DoD, U.S. Government, DOE or ORAU/ORISE.
This research complied with the Animal Welfare Act and adhered to the principles noted in all appropriate AALAS guidelines.

The views expressed are those of the author(s) and do not reflect the official policy of the DoA, DoD, U.S. Government, DOE or ORAU/ORISE.lt;brgt;This research complied with the Animal Welfare Act and adhered to the principles noted in all appropriate AALAS guidelines.